Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,484 total articles
PACS Group has ripped higher from a $7.50 52-week low to the low $40s on improving fundamentals, shrinking leverage and renewed insider confidence. The setup is an actionable long: buy into momentum with a defined stop and a multi-stage target tied to valuation re-rating and normalization of investor sentiment.
Performance Food Group (PFGC) combines industry-leading scale, accelerating sales, and meaningful free cash flow. With shares trading near $95.89, attractive technical momentum and an improving sales outlook, we outline a mid-term swing trade with precise entry, target, and stop levels and balanced risk framing.
ServiceNow is being penalized for 'AI risk' despite a credible path to monetize AI orchestration and strong cash generation. This trade targets a mid-term rebound as the market re-appreciates the Now Platform's role in governance, data fabric integration, and workflow automation.
Atlassian (TEAM) has pulled back into the low $80s on broad SaaS anxiety and macro headlines. Revenue growth and cash generation remain solid, technicals show constructive momentum, and valuation is reasonable vs. growth if you focus on price-to-sales and free cash flow. This is a mid-term trade idea: buy into the fear with a tight stop and a clear…
Caterpillar is benefiting from a surge in data-center and power infrastructure demand tied to AI, but lofty valuation (P/E ~45, EV/EBITDA ~31), high leverage, and a strong recent run-up make CAT a risky name to own here. I prefer strategically shorting CAT over a mid-term horizon while rotating capital into select smaller-exposure rivals that trade…
Snowflake trades at roughly $52.5B market cap and ~11x sales despite negative EPS and decelerating growth. The market is baking in an AI-driven re-acceleration that we think is overstated. This is a tactical mid-term short: entry $152.00, stop $170.00, target $120.00 over ~45 trading days.
Vanda (VNDA) offers asymmetric upside for long-term oriented investors who can stomach near-term earnings and cash-flow pressure. At $6.50 the stock trades at a modest market capitalization relative to its product revenues and pipeline potential; a clean balance sheet and attractive EV/sales leave room for rerating if clinical readouts and commerci…
Replimune (REPL) cratered after an FDA Complete Response Letter for RP1 on 04/10/2026. The stock now trades at $5.295 with heavy volume and stretched short interest. This trade idea outlines a tactical long - entry $5.30, stop $3.90, target $9.00 - sized as a high-risk swing position that plays for a regulatory re-opening, renewed investor focus, o…
Nvidia remains the central beneficiary of a multi‑year AI infrastructure buildout. Recent confirmations from large-scale customers suggest capacity commitments will accelerate, and the market's short-term focus is missing the follow-through. This is a swing trade: enter at market, stop tight below the consolidation band, target material multiple ex…
Snowflake ($SNOW) looks positioned for a short-term squeeze driven by concentrated short interest, active retail short-volume, and fresh AI-driven commercial wins. We lay out a tactical long trade for short term (10 trading days) with clear entry, stop, and target, plus catalysts and a balanced risk framework.
Aritzia (ATZ) is a vertically integrated apparel retailer that commands premium multiples thanks to a tight brand, strong unit economics and disciplined inventory management. We like a tactical long: enter on mild weakness, size for a 180-trading-day hold, and use a defined stop to respect valuation risk.
Gold.com has delivered sizable free cash flow and carries an established quarterly dividend. With the stock under pressure technically ($41.66), the balance sheet and cash generation make a case for a special or enlarged payout later in the year or continued buybacks — a catalyst that could re-rate the name. This trade lays out an entry, stop and t…
Baidu is scheduled to report Q1 results within days. With the company’s AI-chip arm (Kunlunxin) reportedly prepping a Hong Kong IPO, investor enthusiasm has pushed BIDU to a $54.2B market cap and a stretched P/E of 85x. We think the spin/IPO risk and the likelihood of value being carved out make BIDU vulnerable to a mid-term downside; this is a tac…
Topicus shares have been punished as investors grapple with AI-driven transition risk in software verticals. At roughly $65.70 and a market cap near $5.48B, the stock is trading well below its 52-week high and shows technical overshoot. We lay out a mid-term (45 trading days) long trade with entry, stop and target, supported by valuation framing, m…
Coeur Mining ($CDE) is trading below its 52-week high despite a beefed-up production profile, a $750M buyback and a healthy free cash flow base. This trade idea takes a long bias: enter near current levels, position for a 180 trading day horizon, and rely on buybacks, integration of New Gold assets, and FCF conversion to drive multiple expansion as…
Western Alliance (WAL) offers a compelling asymmetric trade: attractive valuation, 12% ROE and a dividend while headline risk has compressed the multiple. This idea outlines a long entry with clear stop and target, catalysts to watch, and a balanced risk framework.
Blue Bird's recent $202 million commercial development looks undervalued when you run the numbers. With a $2.21B market cap, $183.8M in free cash flow and a PE near 17, the stock at $70 offers a risk/reward that favors a mid-term long. We'll lay out a concrete trade plan, catalysts to watch and the risks that could derail the thesis.
Braskem's ADR has ripped to a 52-week high after months of consolidation. Momentum, improving fundamentals in polyethylene/polypropylene markets and a materially discounted market cap create a tradeable setup. This idea lays out an actionable long with entry, stop and targets, plus catalysts and risks.
Insulet (PODD) has been punished after an FDA-classified high-risk recall of certain Omnipod 5 pods. The sell-off prices in a short-term demand shock while the company still shows healthy fundamentals: $10.9B market cap, positive free cash flow of $399.9M, ROE ~23%, and manageable leverage. This trade idea outlines a mid-term (45 trading days) long…
Akamai is trading near its 52-week high after accelerating momentum in cloud and security sales. With a $1.8B Anthropic cloud deal announced in early May and a cash-generative business (free cash flow $854.9M), the company has the financial firepower and product footprint to reaccelerate growth. Valuation is rich at ~50x trailing earnings, so this …
Fresh Del Monte (FDP) is trading below its 50-day and 20-day averages on an oversold RSI while still generating strong free cash flow and paying a healthy dividend. With a market cap around $1.68B, EV/EBITDA of 8.3, and free cash flow of $174.9M, the stock looks attractively valued for a measured buy-the-dip trade over the next 45 trading days.
SanDisk (SNDK) is benefiting from secular AI-driven NAND demand and a defensive capital structure. The name looks tradeable on a disciplined long with an entry at $1454.88, stop at $1350.00, and an initial target of $1600.00 over a mid-term exposure window. The setup balances near-term volatility with multi-quarter secular tailwinds backed by cash …
ACNB trades near $52.80 and offers an attractive earnings multiple, a raised quarterly dividend plus a special payout and a fresh buyback authorization; we like the risk/reward for a long-term (180 trading days) trade with a $60 target and a tight stop below $49.
Meta Platforms trades at $605.37 with a $1.535T market cap, strong free cash flow and high profitability. Technicals show recent weakness, but average daily liquidity and low days-to-cover, combined with reports of low put-call ratios in the options market, create an asymmetric trade: buy mid-dated calls for a measured upside target of $675 with a …
Micron looks less like a cyclical commodity and more like a competitively advantaged supplier of specialized memory for AI infrastructure. Strong revenue acceleration, robust free cash flow, low leverage and sold-out supply for 2026 support continued upside, but stretched multiples and outsized market moves demand tight risk management.
